This eye disease often leads to blindness — which might be prevented by early intervention
The team headed by Dr. Jacqueline Reinhard and Prof. Dr. Andreas Faissner from the Department of Cell Morphology and Molecular Neurobiology in Bochum, together with colleagues from the University Eye Clinic in Bochum, RWTH Aachen University, the University of Toronto and the University of Denver, has published a report on their findings. The article was released on 12 October 2018 in the online edition of the journal Molecular Neurobiology.
Specific and early intervention
The researchers bred mice in which the gene PTP-Meg2 (protein tyrosine phosphatase megakaryocyte 2) was mutated . As a result, the animals suffered from chronic intraocular pressure elevation. The team successfully demonstrated that, in their model, the intraocular pressure elevation was associated with a loss of optic nerve fibres and retinal cells. Using functional analyses, they observed that retinal cells were unable to function properly, either. Moreover, they made the following discovery: glial cells and certain components of the immune system showed a reaction in the animals’ optic nerve and retina. As both aspects may be relevant for neurodegeneration, specific and early intervention into these cellular mechanisms may inhibit glaucoma.
Testing new therapy options
Making use of a genetic screening, the researchers subsequently identified new potential biomarkers. In future, these biomarkers may facilitate early detection of glaucoma; as a result, it will be possible to start therapy at an early stage, before the optic nerve and retina are damaged. The glaucoma-mouse model may, moreover, be used to test new therapy options. Experiments to date have shown that intraocular pressure was reduced and nerve cells were retained in the mice if they were given a drug that had been administered to treat human patients.
The Latest on: Glaucoma
via Google News
The Latest on: Glaucoma
- Patients achieve successful outcomes after Baerveldt implantation by residentson November 14, 2019 at 1:14 pm
Patients with glaucoma who underwent Baerveldt implantation by residents experienced similar outcomes and IOP reduction 1 year postoperatively when compared with implantations performed by glaucoma ...
- Understanding how pressure is regulated in the eye could lead to new treatments for glaucomaon November 14, 2019 at 12:04 pm
Funded by a $2.3 million five-year grant from the National Institutes of Health (NIH) National Eye Institute, this research could help to develop future treatments for glaucoma and other diseases.
- A Conversation With Veteran Cannabis Activist Alice O’Leary Randallon November 14, 2019 at 10:45 am
Alice O’Leary Randall began fighting for patient access to medical cannabis in the 1970s, when she and her husband Robert were arrested in California for growing the one medicine he found could make a ...
- Wangton Capital Corp. Signs a Term Sheet to Acquire Cloud 9 Switzerland - a Producer of Cannabis-infused Consumer and Therapeutic Productson November 14, 2019 at 7:40 am
The products include the first Swiss regulatory compliant Hemp Swiss chocolate, and innovative Cannabinoid based treatments for glaucoma, and asthma, and an innovative CBD nanoparticle transdermal ...
- Fight for Sight funds new project to create UK’s first large-scale glaucoma biobankon November 14, 2019 at 5:31 am
Fight for Sight is funding a project to create the UK’s first large-scale glaucoma biobank, a new tool that will help personalize glaucoma treatment and identify patients most at risk of sight loss.
- Ophthalmology Surgical Devices market to witness excellent revenue growth owing to rapid increase in demandon November 14, 2019 at 2:28 am
Nov 14, 2019 (HTF Market Intelligence via COMTEX) -- The latest research publication released with title "Global Ophthalmology Surgical Devices Market by Type (, Cataract Surgery Devices, Glaucoma ...
- Genetic variation for primary open-angle glaucoma found in those with African ancestryon November 11, 2019 at 11:04 am
Primary open-angle glaucoma may be associated with a genetic variation in individuals with African ancestry, a study found. The multicenter genome-wide association study included 26,295 subjects, of ...
- A subacute model of glaucoma based on limbal plexus cautery in pigmented ratson November 8, 2019 at 2:16 am
Glaucoma is a neurodegenerative disorder characterized by the progressive functional impairment and degeneration of the retinal ganglion cells (RGCs) and their axons, and is the leading cause of ...
- Care pathways for glaucoma detection and monitoring in the UKon November 7, 2019 at 12:24 pm
Glaucoma presents considerable challenges in providing clinically and cost-effective care pathways. While UK population screening is not seen as justifiable, arrangements for case finding have ...
via Bing News